Rachel T. Eguia
bioRxiv · 2019–2020
A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Rachel T. Eguia trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Tal Galili
- Kazutaka Katoh
- Jaime Huerta-Cepas
- Pavel Sagulenko
- L. Jost
- Jesse D. Bloom
- A. Walls
- K. H. Crawford
- Daron M. Standley
- F. Krammer
Who trusts Rachel T. Eguia overall
Papers from Rachel T. Eguia's perspective
Ordered by how strongly the researchers Rachel T. Eguia trusts endorse each paper. Same corpus, a different order for every researcher.
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- Mapping the Antigenic and Genetic Evolution of Influenza Virus
- MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
- Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants
- Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays (bioRxiv)
- Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
- Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor (Science)
- Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants (bioRxiv)
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV (Nature Communications)
- Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Their papers
- Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition (2020) — 934 citations
- Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin (2019) — 97 citations
- Author response: Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin (2019) — 5 citations
- A human coronavirus evolves antigenically to escape antibody immunity (2020) — 216 citations
- Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays (2020) — 780 citations